Literature DB >> 8123501

Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth.

I Cohen, D J Rosen, M Altaras, Y Beyth, J Shapira, D Yigael.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8123501      PMCID： PMC1968870          DOI： 10.1038/bjc.1994.116

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  7 in total

1.  Ovarian cancer and long-term tamoxifen in premenopausal women.

Authors:  D V Spicer; M C Pike; B E Henderson
Journal:  Lancet       Date:  1991-06-08       Impact factor: 79.321

2.  Rapid growth of leiomyoma in patient receiving tamoxifen.

Authors:  P V Dilts; M P Hopkins; A E Chang; R L Cody
Journal:  Am J Obstet Gynecol       Date:  1992-01       Impact factor: 8.661

3.  Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma.

Authors:  C A Sawka; K I Pritchard; A H Paterson; D J Sutherland; D B Thomson; W E Shelley; R E Myers; B G Mobbs; A Malkin; J W Meakin
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

4.  Cystic ovarian necrosis complicating tamoxifen therapy for breast cancer in a premenopausal woman. A case report.

Authors:  C J Jolles; D Smotkin; K L Ford; K P Jones
Journal:  J Reprod Med       Date:  1990-03       Impact factor: 0.142

5.  Ovarian torsion in a premenopausal woman treated with tamoxifen for breast cancer.

Authors:  R L Barbieri; A L Ferracci; J N Droesch; B L Rochelson
Journal:  Fertil Steril       Date:  1993-02       Impact factor: 7.329

6.  Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen.

Authors:  P M Ravdin; N F Fritz; D C Tormey; V C Jordan
Journal:  Cancer Res       Date:  1988-02-15       Impact factor: 12.701

7.  A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer.

Authors:  T J Powles; J R Hardy; S E Ashley; G M Farrington; D Cosgrove; J B Davey; M Dowsett; J A McKinna; A G Nash; H D Sinnett
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640
  7 in total
  6 in total

1.  Gynaecological effects of tamoxifen.

Authors:  S M Ismail
Journal:  J Clin Pathol       Date:  1999-02       Impact factor: 3.411

Review 2.  Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy.

Authors:  Mostafa A Borahay; Ayman Al-Hendy; Gokhan S Kilic; Darren Boehning
Journal:  Mol Med       Date:  2015-04-13       Impact factor: 6.354

Review 3.  Gynaecologic effects of tamoxifen.

Authors:  D Y Kuo; C D Runowicz
Journal:  Med Oncol       Date:  1995-06       Impact factor: 3.064

4.  Tumorigenic effects of tamoxifen on the female genital tract.

Authors:  Kaei Nasu; Noriyuki Takai; Masakazu Nishida; Hisashi Narahara
Journal:  Clin Med Pathol       Date:  2008-03-01

5.  Ovarian cysts in women receiving tamoxifen for breast cancer.

Authors:  M J Mourits; E G de Vries; P H Willemse; K A ten Hoor; H Hollema; W J Sluiter; H W de Bruijn; A G van der Zee
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

Review 6.  The effect of tamoxifen on the genital tract.

Authors:  Sandra A Polin; Susan M Ascher
Journal:  Cancer Imaging       Date:  2008-06-30       Impact factor: 3.909
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.